Hikma Pharmaceuticals PLC (LON:HIK) Receives Average Recommendation of “Moderate Buy” from Analysts
Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price objective […]
More Stories
Bunzl plc (OTCMKTS:BZLFF) Short Interest Update
Bunzl plc (OTCMKTS:BZLFF – Get Free Report) saw a significant increase in short interest in the month of September. As...
Short Interest in Beach Energy Limited (OTCMKTS:BEPTF) Decreases By 7.1%
Beach Energy Limited (OTCMKTS:BEPTF – Get Free Report) was the recipient of a significant decrease in short interest in the...
Cost-Effective Strategies for Enhancing Workplace Safety and Reducing Injuries
Whether it is an office, factory, construction site or any other workplace, keeping employees safe and healthy should always be...
Short Interest in AddLife AB (publ) (OTCMKTS:ADDLF) Expands By 13.5%
AddLife AB (publ) (OTCMKTS:ADDLF – Get Free Report) saw a large growth in short interest during the month of September....
Short Interest in Alvopetro Energy Ltd. (OTCMKTS:ALVOF) Decreases By 8.9%
Alvopetro Energy Ltd. (OTCMKTS:ALVOF – Get Free Report) was the target of a large drop in short interest in September....
Athabasca Oil Co. (OTCMKTS:ATHOF) Short Interest Update
Athabasca Oil Co. (OTCMKTS:ATHOF – Get Free Report) was the target of a large increase in short interest in September....